Sequence Similarity Clusters for the Entities in PDB 2I60

Entity #1 | Chains: G,P
EXTERIOR MEMBRANE GLYCOPROTEIN(GP120) protein, length: 313 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 10 3333
95 % 3 11 3503 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 1.0
PDBFlex
90 % 3 13 2917
70 % 57 185 132
50 % 57 185 159
40 % 57 185 171
30 % 57 188 189
Entity #2 | Chains: L,Q
ANTIBODY 17B LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 11 21 1586
95 % 14 34 1118 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 387 811 2
70 % 1259 2621 1
50 % 2584 5323 1
40 % 2953 6003 1
30 % 3598 7460 1
Entity #3 | Chains: H,R
ANTIBODY 17B HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 11 25 1282
95 % 11 25 1507 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 11 25 1531
70 % 1252 2580 2
50 % 2585 5323 1
40 % 2954 6003 1
30 % 3599 7460 1
Entity #4 | Chains: M,S
[PHE23]M47, SCORPION-TOXIN MIMIC OF CD4 protein, length: 27 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 4 9711
95 % 8 16 1819 Flexibility: Low
Max RMSD: 2.6, Avg RMSD: 0.6
PDBFlex
90 % 8 16 1857
70 % 8 16 1867
50 % 8 17 1846
40 % 8 17 1826
30 % 8 17 1782

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 6DBA 1 A, B nanobody VHH R303 9838
32 5YD4 1 A, C, E, G scFv 4B08 10090
33 5YD3 1 A, C, E, G scFv 4B08 10090
34 2XT1 2 B CAMELID VHH 9 30538
35 5UD9 1 H Fab heavy chain 9606
36 5UD9 2 L Light chain 9606
37 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
38 4P48 1 A Antibody scFv 180 9031
39 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
40 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
41 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
42 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
43 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
44 5J1S 3 C VHH domain BS-2 30538
45 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
46 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
47 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
48 5J1T 3 C VHH domain BS-2 30538
49 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
50 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
51 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
52 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
53 4XCF 1 L 4E10 Fab light chain 9606
54 4XCF 2 H 4E10 Fab heavy chain 9606
55 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
56 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
57 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
58 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
59 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
60 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
61 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
62 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
63 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
64 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
65 5X08 1 H Fab 4E10 Heavy chain 9606
66 5X08 2 L Fab 4E10 Light chain 9606
67 2X1O 1 A, B GELSOLIN NANOBODY 9844
68 4QGY 1 A, B nanobody n25, VH domain 9844
69 5C2B 1 H scFv 3B4 heavy chain 9606
70 4XAW 1 L 4E10 Fab light chain 9606
71 4XAW 2 H 4E10 Fab heavy chain 9606
72 5VNV 1 A Nb.b201 32630
73 4P49 1 A Antibody scFv B8 9031
74 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
75 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
76 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
78 5DXW 1 A PD-L1 nanobody 10090
79 5UCB 1 H Fab Heavy Chain 9606
80 5UCB 2 L Fab Light Chain 9606
81 2VXV 1 H HUMAN IGG ABT-325 9606
82 2VXV 2 L HUMAN IGG ABT-325 9606
83 4N9O 2 B Nanobody Nb484 Nb484 9844
84 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
85 4GXV 1 H, I Antibody 1F1, heavy chain 9606
86 4GXV 2 L, M Antibody 1F1, light chain 9606
87 2VXT 1 H MURINE IGG 125-2H 10090
88 2VXT 3 L MURINE IGG 125-2H 10090
89 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
90 1T2J 1 A M12-Variable Heavy domain 9606
91 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
92 6DBF 2 B InlB specific VHH R303 9838
93 6DBG 2 C, D VHH R303 9838
94 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
95 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
96 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
97 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
98 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
99 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
100 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
101 5W24 1 L 5C4 Fab Light Chain 10090
102 5W24 2 H 5C4 Fab Heavy Chain 10090
103 4HPY 1 H CH59 Fab heavy chain 9606
104 4HPY 2 L CH59 Fab light chain 9606
105 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
106 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
107 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
108 5VM6 1 A single domain camelid nanobody VHH T10 9844
109 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
110 4JG1 1 L Fab light chain 9606
111 4JG1 2 H Fab heavy chain 9606
112 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
113 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
114 4KML 2 B Nanobody 9844
115 5VF2 1 A scFv 2D10 10090
116 5I8C 1 A VRC34.01 Fab heavy chain 9606
117 5I8C 2 B VRC34.01 Fab light chain 9606
118 4O5L 1 L Fab F045-092 light chain 9606
119 4O5L 2 H Fab F045-092 heavy chain 9606
120 5MYX 1 A, C Fab c#24 light chain 10090
121 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
122 4Z9K 2 B VHH2(F5) antibody 30538
123 3IFL 1 L 12A11 FAB antibody light chain 10090
124 3IFL 2 H 12A11 FAB antibody heavy chain 10090
125 5WK2 1 L M116 LIGHT CHAIN 9606
126 5WK2 2 H M116 HEAVY CHAIN FD 9606
127 3PP4 1 H GA101 Fab heavy chain 10090
128 3PP4 2 L GA101 Fab light chain 10090
129 3KDM 1 A, L Immunoglobulin light chain 9606
130 3KDM 2 B, H Immunoglobulin heavy chain 9606
131 5NIV 1 A Light chain of 5D3 Fab 10090
132 5NIV 2 B Heavy chain of 5D3 Fab 10090
133 5N4J 1 L LIGHT CHAIN 9606
134 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
135 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
136 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
137 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
138 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
139 5X4G 1 A 6H8 Fab heavy chain 10090
140 5X4G 2 B 6H8 Fab light chain 10090
141 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
142 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
143 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
144 4PTU 1 A Antibody pn132p2C05, light chain 9606
145 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
146 4TPR 1 L If kappa light chain 10090
147 4TPR 2 H Fab heavy chain 10090
148 5LMW 1 A Nanobody 9844
149 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
150 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
151 3IFN 1 H 12A11 FAB antibody heavy chain 10090
152 3IFN 2 L 12A11 FAB antibody light chain 10090
153 5U3P 1 H DH511.4 Fab Heavy Chain 9606
154 5U3P 2 L DH511.4 Fab Light Chain 9606
155 6BLA 1 H AMM01 Fab Heavy chain 9606
156 6BLA 2 L AMM01 Fab Light chain 9606
157 5NM0 1 A, B, C, D Nb36 9844
158 4TOY 1 H 35O22 Fab Heavy chain 9606
159 4TOY 2 L 35O22 Fab Light chain 9606
160 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
161 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
162 3NPS 2 B S4 FAB HEAVY CHAIN 9606
163 3NPS 3 C S4 FAB LIGHT CHAIN 9606
164 5I4F 1 A scFv 2D10 10090
165 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
166 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
167 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
168 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
169 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
170 5WN9 1 H scFv 2D10 9606
171 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
172 4XC3 1 L 4E10 Fab light chain 9606
173 4XC3 2 H 4E10 Fab heavy chain 9606
174 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
175 4PPT 1 A Engineered single domain VHH antibody 9844
176 3R0M 1 A, B Llama VHH A12 9844
177 4M5Y 1 H, I Fab 5J8 heavy chain 9606
178 4M5Y 2 L, M Fab 5J8 light chain 9606
179 4TQE 1 L If kappa light chain 10090
180 4TQE 2 H Fab heavy chain 10090
181 3ZKQ 2 D XA4813 9844
182 5YY4 1 A scFv 4B08 10090
183 4I13 2 B Protein ca1697 (nanobody) 9844
184 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
185 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
186 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
187 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
188 5C2U 1 B Nanobody Nanobody 9838
189 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
190 5VSI 2 L CH1/Ckappa Fab light chain 9606
191 1XFP 1 A heavy chain antibody VHH domain 9838
192 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
193 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
194 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
195 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
196 5JXA 1 H VRC03 Heavy chain 9606
197 5JXA 2 L VRC03 Light chain 9606
198 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
199 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
200 4POY 1 A VHH-metal 9844
201 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
202 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
203 5NLW 1 A nanobody Nb36 9844
204 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
205 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
206 3NTC 1 L Fab light chain 10090
207 3NTC 2 H Fab heavy chain 10090
208 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
209 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
210 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
211 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
212 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
213 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
214 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
215 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
216 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
217 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
218 6BE3 1 H Fab (F598) Heavy Chain 9606
219 6BE3 2 L Fab (F598) Light Chain 9606
220 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
221 3G9A 2 B Minimizer 9838
222 4NWU 1 H APE1551 Ab Fab heavy chain 9606
223 4NWU 2 L APE1551 Ab Fab light chain 9606
224 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
225 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
226 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
227 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
228 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
229 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
230 5EWI 1 H VRC38.01 Heavy Chain 9606
231 5EWI 2 L VRC38.01 Light Chain 9606
232 5E2W 1 L AT8 LIGHT CHAIN 10090
233 5E2W 2 H AT8 HEAVY CHAIN 10090
234 5MYK 1 A Fab c#17 light chain 10090
235 5MYK 2 B Fab c#17 heavy chain 10090
236 4NZR 1 H PGT135 heavy chain Fab 9606
237 4NZR 2 L PGT135 light chain Fab 9606
238 5MYO 1 A, C Fab c#6 light chain 10090
239 5MYO 2 B, D Fab c#6 heavy chain 10090
240 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
241 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
242 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
243 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
244 5UEL 1 H 354NC102 Fab Heavy Chain 9606
245 5UEL 2 L 354NC102 Fab Light Chain 9606
246 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
247 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
248 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
249 2P43 2 B ANTIBODY CAB-RN05 9838
250 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
251 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
252 5E2V 1 L AT8 LIGHT CHAIN 10090
253 5E2V 2 H AT8 HEAVY CHAIN 10090
254 4KRN 1 A Nanobody/VHH domain EgA1 9844
255 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
256 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
257 4GFT 2 B Nanobody 9844
258 4TVS 2 a, b VHH Domain BS-1 30538
259 4W6Y 2 B Nanobody NbFedF9 9844
260 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
261 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
262 6EZW 1 B VHH antibody BCD090-M2 9844
263 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
264 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
265 5JUE 1 L light chain of UIC2 Fab 10090
266 5JUE 2 H heavy chain of UIC2 Fab 10090
267 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
268 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
269 1UAC 2 H Ig VH,anti-lysozyme 10090
270 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
271 5JR1 1 H 10E8 heavy chain 9606
272 5JR1 2 L 10E8 mature light chain 9606
273 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
274 6CA7 1 L PCT64_13C light chain 9606
275 6CA7 2 H PCT64_13C heavy chain 9606
276 5VF6 1 A single chain variable fragment 9031
277 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
278 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
279 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
280 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
281 5OB5 2 H fAb Heavy chain 9606
282 5OB5 3 L fAb Light chain 9606
283 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
284 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
285 5I66 1 A 8B6 antibody, heavy chain 10090
286 5I66 2 B 8B6 antibody, light chain 10090
287 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
288 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
289 6BZY 1 H 22D11 Heavy Chain 10090
290 6BZY 2 L 22D11 Light Chain 10090
291 3QQ9 1 C, L 101F LIGHT CHAIN 10090
292 3QQ9 2 D, H 101F HEAVY CHAIN 10090
293 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
294 5TKK 3 L mouse antibody vFP5.01 light chain 10090
295 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
296 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
297 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
298 5W6C 1 H UCA Fab heavy chain 9606
299 5W6C 2 L UCA Fab light chain 9606
300 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
301 5I1K 1 L FAB LIGHT CHAIN 9606
302 5I1K 2 H FAB HEAVY CHAIN 9606
303 3OZ9 1 L Fab NC-1 kappa light chain 10090
304 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
305 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
306 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
307 5V7U 1 L CBTAU-22.1 Fab light chain 9606
308 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
309 5UEA 1 A, H Fab Heavy Chain 9606
310 5UEA 3 B, L Fab Light Chain 9606
311 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
312 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
313 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
314 3G5Y 1 A 175 light chain 10090
315 3G5Y 2 B 175 heavy chain 10090
316 5O02 2 C Nanobody (VHH) Nano-4 30538
317 5NMV 1 L Fab light chain 10088
318 5NMV 2 H Fab heavy chain 10088
319 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
320 4N8C 2 L, M Light chain of monoclonal antibody 10090
321 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
322 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
323 4HGW 1 A Antibody Fab fragment, light chain 10090
324 4HGW 2 B Antibody Fab fragment, heavy chain 10090
325 1NLB 1 L antibody 19D9D6 light chain 10090
326 1NLB 2 H antibody 19D9D6 heavy chain 10090
327 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
328 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
329 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
330 3VFG 1 L 3F8 Light Chain 10090
331 3VFG 2 H 3F8 Heavy Chain 10090
332 4X7F 2 C, D Nano-25 Nanobody 30538
333 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
334 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
335 3QRG 1 L Fab light chain 9606
336 3QRG 2 H Fab heavy chain Fd fragment 9606
337 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
338 5M6A 1 A, B, C, D Bence-Jones light chain 9606
339 4LLY 2 B, D light chain Clambda 9606
340 4LGR 2 B Camelid nanobody (VHH3) 30538
341 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
342 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
343 5EZI 1 H Fab c12 heavy chain 9606
344 5EZI 2 L Fab c12 Light chain 9606
345 4K23 1 H anti-uPAR antibody, heavy chain 10090
346 4K23 2 L anti-uPAR antibody, light chain 10090
347 5J57 2 B VHH single chain antibody V5E1 30538
348 3NCJ 1 L Fab15 Mut8 light chain 9606
349 3NCJ 2 H Fab15 Mut8 heavy chain 9606
350 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
351 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
352 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
353 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
354 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
355 5W05 1 L M59 FAB LIGHT CHAIN 10090
356 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
357 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
358 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
359 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
360 5OMM 2 C Nanobody (VHH) Nano-14 30538
361 5E03 1 A mouse CTLA-4 nanobody 10090
362 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
363 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
364 4M61 1 A, C Fab A52 light chain 10090
365 4M61 2 B, D Fab A52 heavy chain 10090
366 5YE3 1 B 2A7D9 VH CH1 chain 10090
367 5YE3 2 A 2A7D9 L chain 10090
368 5LZ0 1 A, B PorM nanobody 9844
369 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
370 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
371 1UM5 1 L Antibody 21H3 L chain 10090
372 1UM5 2 H Antibody 21H3 H chain 10090
373 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
374 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
375 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
376 4NWT 1 L APE1531 Ab Fab light chain 9606
377 4NWT 2 H APE1531 Ab Fab heavy chain 9606
378 6DBE 1 A, B nanobody VHH R303 9844
379 3WHX 1 A mAb Fab H fragment 10090
380 3WHX 2 B mAb Fab L fragment 10090
381 3NA9 1 L Fab15 light chain 9606
382 3NA9 2 H Fab15 heavy chain 9606
383 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
384 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
385 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
386 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
387 4LRI 1 A, B MSL-109 Light Chain 9606
388 4LRI 2 C, P MSL-109 Heavy Chain 9606
389 2XXC 1 B CAMELID VHH 9 30538
390 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
391 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
392 4JN2 1 A, L anti dabigatran Fab 10090
393 4JN2 2 B, H anti dabigatran Fab 10090
394 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
395 4XBE 2 H 4E10 Fab heavy chain 9606
396 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
397 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
398 6BE2 1 H Fab (F598) Heavy Chain 9606
399 6BE2 2 L Fab (F598) Light Chain 9606
400 3QYC 1 A, B VH domain of IgG molecule 9606
401 4JFZ 1 L Fab light chain 9606
402 4JFZ 2 H Fab heavy chain 9606
403 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
404 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
405 5VAK 2 B Nb914 Nanobody 9844
406 3WIF 1 A mAb Fab H fragment 10090
407 3WIF 2 B mAb Fab L fragment 10090
408 5U6A 1 A Light Chain 9606
409 5U6A 2 B Heavy Chain 9606
410 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
411 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
412 3MBX 1 L X836 LIGHT CHAIN 10090
413 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
414 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
415 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
416 2XXM 2 B CAMELID VHH 9 30538
417 6APC 1 H Epididymis luminal protein 214 9606
418 6APC 2 L IGL@ protein 9606
419 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
420 4HHA 1 A Fab KE5 Fab fragment KE5 9606
421 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
422 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
423 4RGO 2 H 14G8 heavy chain Fab 10090
424 4RGO 3 L 14G8 light chain Fab 10090
425 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
426 5GRY 1 A, G diabody 9606
427 5UEK 2 H Fab 12E Heavy Chain 9606
428 5UEK 3 L Fab 12E Light Chain 9606
429 3NAA 1 L Fab15 Mut5 light chain 9606
430 3NAA 2 H Fab15 Mut5 heavy chain 9606
431 6DBD 1 A, B, C, D nanobody VHH R326 9844
432 1Q0X 1 L Fab 9B1, light chain 10090
433 1Q0X 2 H Fab 9B1, heavy chain 10090
434 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
435 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
436 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
437 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
438 5JDS 1 B Nanobody 9835
439 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
440 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
441 5IK3 2 B, D 1E03 Fab fragment light chain 9606
442 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
443 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
444 5XLI 1 a, b FabL 10090
445 5XLI 2 c, d FabH 10090
446 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
447 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
448 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
449 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
450 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
451 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
452 4WUK 1 H CH65 heavy chain 9606
453 4WUK 2 L CH65 light chain 9606
454 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
455 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
456 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
457 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
458 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
459 5JOP 1 D, L Fab 14.22 light chain 10090
460 5JOP 2 E, H Fab14.22 heavy chain 10090
461 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
462 4HPO 1 H CH58 Fab heavy chain 9606
463 4HPO 2 L CH58 Fab light chain 9606
464 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
465 5UKN 2 L DH522UCA Fab fragment light chain 9544
466 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
467 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
468 5L21 2 B VHH-C2 30538
469 5IT2 1 H heavy chain 9606
470 5IT2 2 L light chain 9606
471 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
472 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
473 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
474 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
475 5FWO 1 A NANOBODY 9844
476 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
477 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
478 5MO3 3 L Fab of monoclonal antibody, light chain 10090
479 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
480 5GZ0 1 A, C FM329 light chain 1383439
481 5GZ0 2 B, D FM329 heavy chain 1383439
482 6DW2 1 A 6078 Fab light chain 9606
483 6DW2 2 B 6078 Fab heavy chain 9606
484 3B9V 1 A, B, C, D heavy chain variable domain 9606
485 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
486 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
487 6BQB 1 L MGG4 Fab light chain 9606
488 6BQB 2 H MGG4 Fab heavy chain 9606
489 4PUB 1 H DX-2930 HEAVY CHAIN 9606
490 4PUB 2 L DX-2930 LIGHT CHAIN 9606
491 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
492 6B14 2 L Light chain of Fab BL3-6S97N 10090
493 5N88 1 A, H VH59 antibody 9606
494 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
495 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
496 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
497 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
498 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
499 5GS3 1 A, H diabody protein 9606
500 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
501 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
502 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
503 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
504 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
505 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
506 5VKD 2 H Fab Heavy Chain 9606
507 5VKD 3 L Fab light chain 9606
508 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
509 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
510 5XHG 1 A, C polypeptide(L) 10090
511 5XHG 2 B, D polypeptide(H) 10090
512 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
513 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
514 3UYR 1 H antibody Fab heavy chain 10090
515 3UYR 2 L antibody Fab light chain 10090
516 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
517 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
518 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
519 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
520 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
521 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
522 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
523 3OAZ 2 K, L Fab 2G12, light chain 9606
524 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
525 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
526 1ZAN 1 L Fab AD11 Light Chain 10116
527 1ZAN 2 H Fab AD11 Heavy Chain 10116
528 6CJK 1 A, C Immunoglobulin Fab light chain 9986
529 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
530 4N0Y 1 H IGH526 Heavy Chain 9606
531 4N0Y 2 L IGH526 Light Chain 9606
532 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
533 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
534 5MTH 1 A, H antibody Fab heavy chain 10090
535 5MTH 2 B, L antibody Fab light chain 10090
536 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
537 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
538 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
539 1RZF 1 L Fab E51 light chain 9606
540 1RZF 2 H Fab E51 heavy chain 9606
541 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
542 4KTE 2 L GE148 Light Chain Fab 9544
543 5I8O 1 H HMM5 antibody heavy chain 9606
544 5I8O 2 L HMM5 antibody light chain 9606
545 4OUO 1 A anti Bla g 1 scFv 9031
546 4JG0 1 L Fab light chain 9606
547 4JG0 2 H Fab heavy chain 9606
548 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
549 4YGV 2 B, L aDabi-Fab2a light chain 9606
550 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
551 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
552 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
553 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
554 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
555 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
556 3EO0 1 A, C GC-1008 Fab Light Chain 10090
557 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
558 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
559 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
560 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
561 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
562 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
563 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
564 4POU 2 B VHH Antibody 9844
565 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
566 4FQI 3 H antibody CR9114 heavy chain Fab 9606
567 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
568 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
569 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
570 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
571 4JHA 2 L D25 light chain 9606
572 6B9Z 1 A Trastuzumab Fab light chain 10090
573 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
574 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
575 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
576 4PTT 1 A Antibody pn132p2C05, light chain 9606
577 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
578 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
579 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
580 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
581 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
582 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
583 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
584 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
585 2P42 2 B, D ANTIBODY CAB-RN05 9838
586 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
587 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
588 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
589 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
590 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
591 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
592 4DGV 1 H HCV1 Heavy Chain Fab 9606
593 4DGV 2 L HCV1 Light Chain 9606
594 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
595 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
596 5TH2 1 A, C cetuximab Fab, light chain 10090
597 5TH2 2 B, D cetuximab Fab, heavy chain 10090
598 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
599 5I8K 1 L HHH1 Fab Light chain 9606
600 5I8K 2 H HHH1 Fab Heavy chain 9606
601 4QLR 1 A, B Llama nanobody n02 VH domain 9844
602 5J56 2 B VHH single chain antibody V1C7 30538
603 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
604 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
605 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
606 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
607 1YNL 1 L Ig gamma light chain 10090
608 1YNL 2 H Ig gamma heavy chain 10090
609 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
610 5EPM 2 B, F Antibody Fab fragment light chain 10090
611 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
612 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
613 3UMT 1 A scFv heavy chain and light chain 10090
614 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
615 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
616 4NUJ 1 A PGT152 light chain 9606
617 4NUJ 2 B PGT152 heavy chain 9606
618 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
619 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
620 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
621 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
622 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
623 3U2S 2 B, L PG9 light chain 9606
624 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
625 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
626 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
627 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
628 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
629 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
630 4NUG 1 L PGT151 light chain 9606
631 4NUG 2 H PGT151 heavy chain 9606
632 3IU4 1 H chP3 Fab heavy chain 10090
633 3IU4 2 L chP3 Fab light chain 10090
634 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
635 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
636 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
637 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
638 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
639 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
640 1P7K 1 A, L antibody light chain FAB 10090
641 1P7K 2 B, H antibody heavy chain FAB 10090
642 4NBX 2 B A20.1 VHH 9844
643 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
644 3RVV 2 C 4C1 - light chain 10090
645 3RVV 3 D 4C1 - heavy chain 10090
646 4HEP 2 G vHH17 domain 9844
647 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
648 3P0Y 2 H Fab DL11 heavy chain 9606
649 3P0Y 3 L Fab DL11 light chain 9606
650 4NPY 1 A, L germline PGT121 light chain Fab 9606
651 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
652 6ANA 2 H LL2 Fab Heavy Chain 10090
653 6ANA 3 L LL2 Fab Light Chain 10090
654 5IBU 1 B, L 6652 Light Chain 9606
655 5IBU 2 G, H 6652 Heavy Chain 9606
656 5VPL 2 C 4C1 - LIGHT CHAIN 10090
657 5VPL 3 D 4C1 - HEAVY CHAIN 10090
658 6AOD 1 A FXIa Antibody FAB Light Chain 9606
659 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
660 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
661 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
662 2YPV 2 H FAB 12C1 10090
663 2YPV 3 L FAB 12C1 10090
664 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
665 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
666 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
667 4JY5 1 L PGT122 light chain Fab 9606
668 4JY5 2 H PGT122 heavy chain Fab 9606
669 6ELE 1 A, H fAB heavy chain 9606
670 6ELE 2 B, L fAB light chain 9606
671 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
672 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
673 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
674 6B5R 1 H CIS42 Fab Heavy chain 9606
675 6B5R 2 L CIS42 Fab Light chain 9606
676 5IML 2 B Nanobody 9835
677 3NAC 1 L Fab15 Mut7 light chain 9606
678 3NAC 2 H Fab15 Mut7 heavy chain 9606
679 3A6C 2 H IG VH, anti-lysozyme 10090
680 2DQD 2 H Ig VH,anti-lysozyme 10090
681 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
682 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
683 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
684 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
685 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
686 1Q72 1 L Fab M82G2, Light chain 10090
687 1Q72 2 H Fab M82G2, Heavy chain 10090
688 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
689 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
690 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
691 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
692 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
693 4YHO 1 H aDabi-Fab3 heavy chain 9606
694 4YHO 2 L aDabi-Fab3 light chain 9606
695 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
696 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
697 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
698 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
699 4DGY 1 H HCV1 Heavy Chain Fab 9606
700 4DGY 2 L HCV1 Light Chain 9606
701 3A67 2 H IG VH, anti-lysozyme 10090
702 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
703 5EN2 1 A GD01 heavy chain 10090
704 5EN2 2 B GD01 light chain 10090
705 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
706 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
707 1J1X 2 H Ig VH,anti-lysozyme 10090
708 5M2J 2 D Anti-(ED-B) scFV 9606
709 3MXW 2 L 5E1 light chain 9606
710 3MXW 3 H 5E1 heavy chain 9606
711 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
712 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
713 2DQC 2 H Ig VH,anti-lysozyme 10090
714 1J1O 2 H Ig VH,anti-lysozyme 10090
715 3EO9 1 L Efalizumab Fab fragment, light chain 9606
716 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
717 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
718 4M62 2 H, I GEP2 FV heavy chain 9606
719 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
720 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
721 5IVO 1 A BC2-nanobody 30538
722 1J1P 2 H Ig VH,anti-lysozyme 10090
723 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
724 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
725 4NBZ 2 B, D A26.8 VHH 9844
726 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
727 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
728 5WUV 1 L light chain 9606
729 5WUV 2 H heavy chain 9606
730 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
731 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
732 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
733 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
734 5AYU 2 H Ig VH,anti-lysozyme 10090
735 4JM4 1 H PGT 135 Heavy Chain Fab 9606
736 4JM4 2 L PGT 135 Light Chain Fab 9606
737 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
738 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
739 3A6B 2 H IG VH, anti-lysozyme 10090
740 2DQJ 2 H Ig VH,anti-lysozyme 10090
741 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
742 5YE4 2 B, D 1A9D7 L chain 10090
743 5F21 2 B nanobody MU375 9844
744 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
745 6B0G 1 C 1245 Antibody, Light Chain 9606
746 6B0G 2 D 1245 Antibody, Heavy Chain 9606
747 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
748 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
749 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
750 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
751 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
752 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
753 6D0X 1 A 2140 Antibody, heavy chain 9606
754 6D0X 2 B 1210 Antibody, light chain 9606
755 2P44 2 B ANTIBODY CAB-RN05 9838
756 6BE4 1 H Fab (F598) Heavy Chain 9606
757 6BE4 2 L Fab(F598) Light Chain 9606
758 5TPP 1 L DH270.5 Fab heavy chain 9606
759 5TPP 2 H DH270.5 Fab light chain 9606
760 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
761 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
762 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
763 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
764 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
765 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
766 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
767 5TP3 1 A, B F-VHH-4 9844
768 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
769 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
770 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
771 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
772 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
773 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
774 5TL5 1 L M2177 LIGHT CHAIN 10090
775 5TL5 2 H M2177 HEAVY CHAIN 10090
776 2FX7 1 L Fab 4E10 Light Chain 9606
777 2FX7 2 H Fab 4E10 Heavy Chain 9606
778 5Y9K 1 L belimumab light chain 9606
779 5Y9K 2 H belimumab heavy chain 9606
780 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
781 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
782 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
783 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
784 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
785 4LHJ 2 B Camelid antibody 30538
786 3WFH 1 A mAb Fab H fragment 10090
787 3WFH 2 B mAb Fab L fragment 10090
788 4BEL 2 D, E XA4813 9844
789 5M7Q 1 A, B Nanobody NbD2 9838
790 5H8D 1 A VHH nanobody 9844
791 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
792 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
793 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
794 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
795 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
796 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
797 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
798 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
799 3DUR 2 B, D Ig-like protein 10090
800 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
801 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
802 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
803 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
804 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
805 5HI4 3 D, L CAT-2000 FAB light chain 9606
806 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
807 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
808 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
809 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
810 3RVW 2 C 4C1 - light chain 10090
811 3RVW 3 D 4C1 - heavy chain 10090
812 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
813 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
814 5XKU 2 B HNIgGA6 light chain 9606
815 5XKU 3 C HNIgGA6 heavy chain 9606
816 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
817 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
818 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
819 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
820 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
821 5HI5 3 D, L CAT-2000 light chain 9606
822 5JO5 1 A, C, E, H 10E8 gHV 9606
823 5JO5 2 B, D, F, L 10E8 gLV 9606
824 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
825 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
826 2XV6 2 B, D CAMELID VHH 9 30538
827 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
828 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
829 5CCK 2 L Antibody 3BC315 Fab light chain 9606
830 5VM0 1 A, B Camelid Nanobody VHH T9 9844
831 5I76 1 A, C FM318_light_chain 1383439
832 5I76 2 B, D FM318_heavy_cahin 1383439
833 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
834 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
835 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
836 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
837 5I18 1 L FAB LIGHT CHAIN 9606
838 5I18 2 H FAB HEAVY CHAIN 9606
839 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
840 4JN1 2 L anti-dabigatran Fab1, light chain 10090
841 4ZG1 1 A, B, C, D, E, F NB17 9844
842 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
843 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
844 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
845 4G5Z 2 L canakinumab antibody fragment light chain 9606
846 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
847 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
848 2OK0 2 L Fab ED10 light chain 10090
849 2OK0 3 H Fab ED10 heavy chain 10090
850 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
851 3SOB 1 L antibody light chain 9606
852 3SOB 3 H antibody heavy chain 9606
853 6B5M 1 H CIS43 Fab Heavy chain 9606
854 6B5M 2 L CIS43 Fab Light chain 9606
855 4I1N 2 B Protein ca1697 (nanobody) 9844
856 5AWN 1 H Heavy chain of 3BC176 Fab 9606
857 5AWN 2 L Light chain of 3BC176 Fab 9606
858 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
859 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
860 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
861 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
862 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
863 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
864 5DR5 2 L AbD09097 Fab light chain 9606
865 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
866 2IH3 1 A FAB Heavy Chain 10090
867 2IH3 2 B FAB Light Chain 10090
868 4KQ3 1 L CNTO3186 light chain Fab 9606
869 4KQ3 2 H CNTO3186 heavy chain Fab 9606
870 6F0D 1 A, B VHH antibody BCD090-M2 9844
871 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
872 6AQ7 3 L POM6 FAB light CHAIN 10090
873 4JFX 1 A, L Fab light chain 9606
874 4JFX 2 B, H Fab heavy chain 9606
875 3SGE 1 I, L Light Chain 10090
876 3SGE 2 H, J Heavy Chain 10090
877 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
878 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
879 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
880 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
881 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
882 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
883 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
884 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
885 5FHB 1 H Antibody 100 Fab heavy chain 9606
886 5FHB 2 L Antibody 100 Fab light chain 9606
887 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
888 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
889 1JGU 1 L Antibody Light Chain 10090
890 1JGU 2 H Antibody Heavy Chain 10090
891 4I77 1 H Lebrikizumab heavy chain Fab 9606
892 4I77 2 L Lebrikizumab light chain Fab 9606
893 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
894 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
895 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
896 4O4Y 2 H 2095-2 heavy chain 9986
897 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
898 5OBF 1 H fAb Heavy chain 10090
899 5OBF 2 L fAb Light chain 10090
900 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
901 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
902 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
903 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
904 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
905 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
906 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
907 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
908 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
909 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
910 5MHE 1 L Fab-fragment 10090
911 5MHE 2 H Fab-fragment 10090
912 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
913 4GLR 3 I, K anti-ptau light chain light chain 9031
914 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
915 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
916 4HJG 1 A Trastuzumab light chain 9606
917 4HJG 2 B Trastuzumab heavy chain 9606
918 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
919 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
920 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
921 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
922 5I30 1 L Fab PL-2 light chain 10090
923 5I30 2 H Fab PL-2 heavy chain 10090
924 4W6X 2 B Nanobody NbFedF7 9844
925 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606